Ovarian epithelial cancer stem cells

TheScientificWorldJournal

Volumn 11, Issue , 2011, Pages 1243-1269

  Conic, Irena ^a   Dimov, Irena ^a   Tasic Dimov, Desanka ^a   Djordjevic, Biljana ^a   Stefanovic, Vladisav ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Cancer stem cell; Chemoresistance; Ovarian epithelial cancer; Pathogenesis; Signaling pathways; Therapy

Indexed keywords

BETA CATENIN; DOXORUBICIN; MESSENGER RNA; METHOTREXATE; NOTCH RECEPTOR; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; SONIC HEDGEHOG PROTEIN; WNT PROTEIN;

CANCER RESISTANCE; CANCER STEM CELL; CELL FUNCTION; CELL HETEROGENEITY; CELL ISOLATION; DISEASE COURSE; EPITHELIUM OVARY CANCER STEM CELL; HUMAN; LABORATORY TEST; NONHUMAN; OVARY CANCER; PATHOGENESIS; REVIEW; SIGNAL TRANSDUCTION;

DRUG RESISTANCE, NEOPLASM; EPITHELIUM; FEMALE; HEDGEHOG PROTEINS; HUMANS; MICRORNAS; NEOPLASTIC STEM CELLS; OVARIAN NEOPLASMS; PROTO-ONCOGENE PROTEINS C-AKT; PTEN PHOSPHOHYDROLASE; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION;

EID: 79959664464     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/tsw.2011.112     Document Type: Review

References (257)

1. Jemal, A., Murray, T., Ward, E., Samuels, A., Tiwari, R.C., Ghafoor, A., Feuer, E.J., and Thun, M.J. (2005) Cancer statistics, 2005. CA Cancer J. Clin. 55, 10-30. (Pubitemid 40310185)
2. Aletti, G.D., Gallenberg, M.M., Cliby, W.A., Jatoi, A., and Hartmann, L.C. (2007) Current management strategies for ovarian cancer. Mayo Clin. Proc. 82, 751-770. (Pubitemid 46878099)
3. Chen, V.W., Ruiz, B., Killeen, J.L., Coté, T.R., Wu, X.C., and Correa, C.N. (2003) Pathology and classification of ovarian tumors. Cancer 97, 2631-2642. (Pubitemid 36539064)
4. Altekruse, S.F., Kosary, C.L., Krapcho, M., Neyman, N., Aminou, R., Waldron, W., Ruhl, J., Howlader, N., Tatalovich, Z., Cho, H., Mariotto, A., Eisner, M.P., Lewis, D.R., Cronin, K., Chen, H.S., Feuer, E.J., Stinchcomb, D.G., and Edwards, B.K., Eds. (2010) SEER Cancer Statistics Review, 1975-2007. National Cancer Institute, Bethesda, MD. http://seer.cancer.gov/csr/1975-2007/
5. Tavassoli, F.A. and Devilee, P., Eds. (2003) Pathology and Genetics. Tumours of the Breast and Female Genital Organs. International Agency for Research on Cancer and World Health Organization, IARC Press, Lyon, France.
6. Dubeau, L. (2008) The cell of origin of ovarian epithelial tumours. Lancet Oncol. 9, 1191-1197.
7. Karst A.M. and Drapkin, R. (2010) Ovarian cancer pathogenesis: a model in evolution. J. Oncol. 2010, 932371.
8. Clarke, M.F., Dick, J.E., Dirks, P., Eaves, C.J., Jamieson, C.H.M., Jones, D.L., Visvader, J., Weissman, I.L., and Wahl, G.M. (2006) Cancer stem cells - perspectives on current status and future directions: AACR Workshop on Cancer Stem Cells. Cancer Res. 66, 9339-9344. (Pubitemid 44623625)
9. Al-Hajj, M., Wicha, M.S., Benito-Hernandez, A., Morrison, S.J., and Clarke, M.F. (2003) Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. U. S. A. 100, 3983-3988. (Pubitemid 36418143)
10. Singh, S.K., Hawkins, C., Clarke, I.D., Squire, J.A., Bayani, J., Hide, T., Henkelman, R.M., Cusimano, M.D., and Dirks, P.B. (2004) Identification of human brain tumour initiating cells. Nature 432, 396-401. (Pubitemid 39551674)
11. Collins, A.T., Berry, P.A., Hyde, C., Stower, M.J., and Maitland, N.J. (2005) Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res. 65, 10946-10951. (Pubitemid 41713363)
12. He, X., Marchionni, L., Hansel, D.E., Yu, W., Sood, A., Yang, J., Parmigiani, G., Matsui, W., and Berman, D.M. (2009) Differentiation of a highly tumorigenic basal cell compartment in urothelial carcinoma. Stem Cells 27, 1487-1495.
13. Li, C., Lee, C.J., and Simeone, D.M. (2009) Identification of human pancreatic cancer stem cells. Methods Mol. Biol. 568, 161-173.
14. O'Brien, C.A., Pollett, A., Gallinger, S., and Dick, J.E. (2007) A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445, 106-110. (Pubitemid 46067310)
15. Maitland, N.J. and Collins, A.T. (2008) Prostate cancer stem cells: a new target for therapy. J. Clin. Oncol. 26, 2862-2870.
16. Schatton, T., Murphy, G.F., Frank, N.Y., Yamaura, K., Waaga-Gasser, A.M., Gasser, M., Zhan, Q., Jordan, S., Duncan, L.M., Weishaupt, C., Fuhlbrigge, R.C., Kupper, T.S., Sayegh, M.H., and Frank, M.H. (2008) Identification of cells initiating human melanomas. Nature 451, 345-349.
17. Shih, Ie.M. and Kurman, R.J. (2004) Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis. Am. J. Pathol. 164, 1511-1518.
18. Singer, G., Stöhr, R., Cope, L., Dehari, R., Hartmann, A., Cao, D.F., Wang, T.L., Kurman, R.J., and Shih, I.M. (2005) Patterns of p53 mutations separate ovarian serous borderline tumors and low- and high-grade carcinomas and provide support for a new model of ovarian carcinogenesis: a mutational analysis with immunohistochemical correlation. Am. J. Surg. Pathol. 29, 218-224. (Pubitemid 40170640)
19. Kurman, R.J. and Shih, Ie.M. (2008) Pathogenesis of ovarian cancer: lessons from morphology and molecular biology and their clinical implications. Int. J. Gynecol. Pathol. 27, 151-160. (Pubitemid 351450677)
20. Kurman, R.J. and Shih, I.M. (2010) The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory. Am. J. Surg. Pathol. 34, 433-443.
21. Pittenger, M.F., Mackay, A.M., Beck, S.C., Jaiswal, R.K., Douglas, R., Mosca, J.D., Moorman, M.A., Simonetti, D.W., Craig, S., and Marshak, D.R. (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284, 143-147. (Pubitemid 29282067)
22. Berardi, A.C., Wang, A., Levine, J.D., Lopez, P., and Scadden, D.T. (1995) Functional isolation and characterization of human hematopoietic stem cells. Science 267, 104-108.
23. Michel, M., Török, N., Godbout, M.J., Lussier, M., Gaudreau, P., Royal, A., and Germain, L. (1996) Keratin 19 as a biochemical marker of skin stem cells in vivo and in vitro: keratin 19 expressing cells are differentially localized in function of anatomic sites, and their number varies with donor age and culture stage. J. Cell Sci. 109, 1017-1028.
24. Toma, J.G., Akhavan, M., Fernandes, K.J., Barnabé-Heider, F., Sadikot, A., Kaplan, D.R., and Miller, F.D. (2001) Isolation of multipotent adult stem cells from the dermis of mammalian skin. Nat. Cell Biol. 3, 778-784. (Pubitemid 32842682)
25. Barker, N., van Es, J.H., Kuipers, J., Kujala, P., van den Born, M., Cozijnsen, M., Haegebarth, A., Korving, J., Begthel, H., Peters, P.J., and Clevers. H. (2007) Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 449, 1003-1007. (Pubitemid 350014593)
26. Lopez-Garcia, C., Klein, A.M., Simons, B.D., and Winton, D.J. (2010) Intestinal stem cell replacement follows a pattern of neutral drift. Science 330, 822-825.
27. Dontu, G., Abdallah, W.M., Foley, J.M., Jackson, K.W., Clarke, M.F., Kawamura, M.J., and Wicha, M.S. (2003) In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev. 17, 1253-1270. (Pubitemid 36583168)
28. Swain, A. and Lovell-Badge, R. (1999) Mammalian sex determination: a molecular drama. Genes Dev. 13, 755-767. (Pubitemid 29169835)
29. Loffler, K.A and Koopman, P. (2002) Charting the course of ovarian development in vertebrates. Int. J. Dev. Biol. 46, 503-510. (Pubitemid 36841018)
30. Auersperg, N., Wong, A.S., Choi, K.C., Kang, S.K., and Leung, P.C. (2001) Ovarian surface epithelium: biology, endocrinology, and pathology. Endocr. Rev. 22, 255-288. (Pubitemid 32458162)
31. Oktem, O. and Oktay, K. (2008) The ovary: anatomy and function throughout human life. Ann. N. Y. Acad. Sci. 1127, 1-9. (Pubitemid 351563102)
32. Murdoch, W.J., Townsend, R.S., and McDonnel, A.C. (2001) Ovulation-induced DNA damage in ovarian surface epithelial cells of ewes: prospective regulatory mechanisms of repair/survival and apoptosis. Biol. Reprod. 65, 1417-1424. (Pubitemid 33031499)
33. Murdoch, W.J. and McDonnel, A.C. (2002) Roles of the ovarian surface epithelium in ovulation and carcinogenesis. Reproduction 123, 743-750. (Pubitemid 34662050)
34. Young, R.H. (2005) A brief history of the pathology of the gonads. Mod. Pathol. 18, S3-S17.
35. Okamoto, S., Okamoto, A., Nikaido, T., Saito, M., Takao, M., Yanaihara, N., Takakura, S., Ochiai, K., and Tanaka, T. (2009) Mesenchymal to epithelial transition in the human ovarian surface epithelium focusing on inclusion cysts. Oncol. Rep. 21, 1209-1214.
36. Kurman, R.J., Visvanathan, K., Roden, R., Wu, T.C., and Shih, I.M. (2008) Early detection and treatment of ovarian cancer: shifting from early stage to minimal volume of disease based on a new model of carcinogenesis. Am. J. Obstet. Gynecol. 198, 351-356. (Pubitemid 351451941)
37. Lin, H. (2002) The stem-cell niche theory: lessons from flies. Nat. Rev. Genet. 3, 931-940.
38. Kirilly, D. and Xie, T. (2007) The Drosophila ovary: an active stem cell community. Cell Res. 17, 15-25. (Pubitemid 46096420)
39. Song, X., Call, G.B., Kirilly, D., and Xie, T. (2007) Notch signaling controls germline stem cell niche formation in the Drosophila ovary. Development 134, 1071-1080. (Pubitemid 46630075)
40. Nystul, T. and Spradling, A. (2010) Regulation of epithelial stem cell replacement and follicle formation in the Drosophila ovary. Genetics 184, 503-515.
41. Li, X., Han, Y., and Xi, R. (2010) Polycomb group genes Psc and Su(z)2 restrict follicle stem cell self-renewal and extrusion by controlling canonical and noncanonical Wnt signaling. Genes Dev. 24, 933-946.
42. Jagarlamudi, K., Liu, L., Adhikari, D., Reddy, P., Idahl, A., Ottander, U., Lundin, E., and Liu, K. (2009) Oocyte-specific deletion of Pten in mice reveals a stage-specific function of PTEN/PI3K signaling in oocytes in controlling follicular activation. PLoS One 4, e6186.
43. Ren, Y., Cowan, R.G., Harman, R.M., and Quirk, S.M. (2009) Dominant activation of the hedgehog signaling pathway in the ovary alters theca development and prevents ovulation. Mol. Endocrinol. 23, 711-723.
44. Ahmed, N., Maines-Bandiera, S., Quinn, M.A., Unger, W.G., Dedhar, S., and Auersperg, N. (2006) Molecular pathways regulating EGF-induced epithelio-mesenchymal transition in human ovarian surface epithelium. Am. J. Physiol. Cell Physiol. 290, C1532-1542.
45. Tingen, C., Kim, A., and Woodruff, T.K. (2009) The primordial pool of follicles and nest breakdown in mammalian ovaries. Mol. Hum. Reprod. 15, 795-803.
46. Cotsarelis, G., Sun, T.T., and Lavker, R.M. (1990) Label-retaining cells reside in the bulge area of pilosebaceous unit: implications for follicular stem cells, hair cycle, and skin carcinogenesis. Cell 61, 1329-1337.
47. Tumbar, T., Guasch, G., Greco, V., Blanpain, C., Lowry, W.E., Rendl, M., and Fuchs, E. (2004) Defining the epithelial stem cell niche in skin. Science 303, 359-363. (Pubitemid 38095773)
48. Welm, B., Behbod, F., Goodell, M.A., and Rosen, J.M. (2003) Isolation and characterization of functional mammary gland stem cells. Cell Prolif. 36, 17-32. (Pubitemid 37521841)
49. Brisken, C. and Duss, S. (2007) Stem cells and the stem cell niche in the breast: an integrated hormonal and developmental perspective. Stem Cell Rev. 3, 147-156. (Pubitemid 350129717)
50. Virant-Klun, I., Rozman, P., Cvjeticanin, B., Vrtacnik-Bokal, E., Novakovic, S., Rülicke, T., Dovc, P., and Meden-Vrtovec, H. (2009) Parthenogenetic embryo-like structures in the human ovarian surface epithelium cell culture in postmenopausal women with no naturally present follicles and oocytes. Stem Cells Dev. 18, 137-149.
51. Szotek, P.P., Chang, H.L., Brennand, K., Fujino, A., Pieretti-Vanmarcke, R., Lo Celso, C., Dombkowski, D., Preffer, F., Cohen, K.S., Teixeira, J., and Donahoe, P.K. (2008) Normal ovarian surface epithelial label-retaining cells exhibit stem/progenitor cell characteristics. Proc. Natl. Acad. Sci. U. S. A. 105, 12469-12473.
52. Bukovsky, A., Caudle, M.R., Svetlikova, M., and Upadhyaya, N.B. (2004) Origin of germ cells and formation of new primary follicles in adult human ovaries. Reprod. Biol. Endocrinol. 2, 20.
53. Bukovsky, A., Svetlikova, M., and Caudle, MR. (2005) Oogenesis in cultures derived from adult human ovaries. Reprod. Biol. Endocrinol. 3, 17.
54. Kossowska-Tomaszczuk, K., De Geyter, C., De Geyter, M., Martin, I., Holzgreve, W., Scherberich, A., and Zhang, H. (2009) The multipotency of luteinizing granulosa cells collected from mature ovarian follicles. Stem Cells 27, 210-219.
55. Jonker, J.W., Freeman, J., Bolscher, E., Musters, S., Alvi, A.J., Titley, I., Schinkel, A.H., and Dale, T.C. (2005) Contribution of the ABC transporters Bcrp1 and Mdr1a/1b to the side population phenotype in mammary gland and bone marrow of mice. Stem Cells 23, 1059-1065.
56. Szotek, P.P., Pieretti-Vanmarcke, R., Masiakos, P.T., Dinulescu, D.M., Connolly, D., Foster, R., Dombkowski, D., Preffer, F., MacLaughlin, D.T., and Donahoe, P.K. (2006) Ovarian cancer side population defines cells with stem cell-like characteristics and Müllerian inhibiting substance responsiveness. Proc. Natl. Acad. Sci. U. S. A. 103, 11154-11159. (Pubitemid 44156488)
57. Ono, M., Maruyama, T., Masuda, H., Kajitani, T., Nagashima, T., Arase, T., Ito, M., Ohta, K., Uchida, H., Asada, H., Yoshimura, Y., Okano, H., and Matsuzaki, Y. (2007) Side population in human uterine myometrium displays phenotypic and functional characteristics of myometrial stem cells. Proc. Natl. Acad. Sci. U. S. A. 104, 18700-18705. (Pubitemid 350210760)
58. Kruk, P.A. and Auersperg, N. (1992) Human ovarian surface epithelial cells are capable of physically restructuring extracellular matrix. Am. J. Obstet. Gynecol. 167, 1437-1443.
59. Auersperg, N., Maines-Bandiera, S.L., Dyck, H.G., and Kruk, P.A. (1994) Characterization of cultured human ovarian surface epithelial cells: phenotypic plasticity and premalignant changes. Lab. Invest. 71, 510-518. (Pubitemid 24338158)
60. Kruk, P.A., Uitto, V.J., Firth, J.D., Dedhar, S., and Auersperg, N. (1994) Reciprocal interactions between human ovarian surface epithelial cells and adjacent extracellular matrix. Exp. Cell Res. 215, 97-108. (Pubitemid 24339179)
61. Auersperg, N., Pan, J., Grove, B.D., Peterson, T., Fisher, J., Maines-Bandiera, S., Somasiri, A., and Roskelley, C.D. (1999) E-cadherin induces mesenchymal-to-epithelial transition in human ovarian surface epithelium. Proc. Natl. Acad. Sci. U. S. A. 96, 6249-6254. (Pubitemid 29256651)
62. Bukovsky, A., Gupta, S.K., Virant-Klun, I., Upadhyaya, N.B., Copas, P., Van Meter, S.E., Svetlikova, M., Ayala, M.E., and Dominguez, R. (2008) Study origin of germ cells and formation of new primary follicles in adult human and rat ovaries. Methods Mol. Biol. 450, 233-265.
63. Godwin, A.K., Testa, J.R., and Hamilton, T.C. (1993) The biology of ovarian cancer development. Cancer 71, 530-536. (Pubitemid 23021247)
64. Ness, R.B. and Cottreau, C. (1999) Possible role of ovarian epithelial inflammation in ovarian cancer. Natl. Cancer Inst. 91, 1459-1467. (Pubitemid 29424550)
65. Folkins, A.K., Jarboe, E.A., Roh, M.H., and Crum, C.P. (2009) Precursors to pelvic serous carcinoma and their clinical implications. Gynecol. Oncol. 113, 391-396.
66. Murdoch, W.J. and Martinchick, J.F. (2004) Oxidative damage to DNA of ovarian surface epithelial cells affected by ovulation: carcinogenic implication and chemoprevention. Exp. Biol. Med. 229, 546-552. (Pubitemid 38736324)
67. Godwin, A.K., Testa, J.R., Handel, L.M., Liu, Z., Vanderveer, L.A., Tracey, P.A., and Hamilton, T.C. (1992) Spontaneous transformation of rat ovarian surface epithelial cells: association with cytogenetic changes and implications of repeated ovulation in the etiology of ovarian cancer. J. Natl. Cancer Inst. 84, 592-601.
68. Testa, J.R., Getts, L.A., Salazar, H., Liu, Z., Handel, L.M., Godwin, A.K., and Hamilton, T.C. (1994) Spontaneous transformation of rat ovarian surface epithelial cells results in well to poorly differentiated tumors with a parallel range of cytogenetic complexity. Cancer Res. 54, 2778-2784. (Pubitemid 24173774)
69. Landen, C.N., Jr., Birrer, M.J., and Sood, A.K. (2008) Early events in the pathogenesis of epithelial ovarian cancer. J. Clin. Oncol. 26, 995-1005. (Pubitemid 351398093)
70. Leeper, K., Garcia, R., Swisher, E., Goff, B., Greer, B., and Paley, P. (2002) Pathologic findings in prophylactic oophorectomy specimens in high-risk women. Gynecol. Oncol. 87, 52-56. (Pubitemid 36027101)
71. Carcangiu, M.L., Radice, P., Manoukian, S., Spatti, G., Gobbo, M., Pensotti, V., Crucianelli, R., and Pasini, B. (2004) Atypical epithelial proliferation in fallopian tubes in prophylactic salpingo-oophorectomy specimens from BRCA1 and BRCA2 germline mutation carriers. Int. J. Gynecol. Pathol. 23, 35-40. (Pubitemid 38018235)
72. Medeiros, F., Muto, M.G., Lee, Y., Elvin, J.A., Callahan, M.J., Feltmate, C., Garber, J.E., Cramer, D.W., and Crum, C.P. (2006) The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome. Am. J. Surg. Pathol. 30, 230-236. (Pubitemid 43740193)
73. Singer, G., Oldt, R., 3rd, Cohen, Y., Wang, B.G., Sidransky, D., Kurman, R.J., and Shih, I.M. (2003) Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma. J. Natl. Cancer Inst. 95, 484-486. (Pubitemid 36432423)
74. Ho, C.L., Kurman, R.J., Dehari, R., Wang, T.L., and Shih, I.M. (2004) Mutations of BRAF and KRAS precede the development of ovarian serous borderline tumors. Cancer Res. 64, 6915-6918. (Pubitemid 39330999)
75. Janda, E., Lehmann, K., Killisch, I., Jechlinger, M., Herzig, M., Downward, J., Beug, H, and Grünert, S. (2002) Ras and TGF[beta] cooperatively regulate epithelial cell plasticity and metastasis: dissection of Ras signaling pathways. J. Cell Biol. 156, 299-313. (Pubitemid 34839911)
76. Shih, Ie.M. and Kurman, R.J. (2005) Molecular pathogenesis of ovarian borderline tumors: new insights and old challenges. Clin. Cancer Res. 11, 7273-7279.
77. Shahbazian, D., Roux, P.P., Mieulet, V., Cohen, M.S., Raught, B., Taunton, J., Hershey, J.W., Blenis, J., Pende, M., and Sonenberg, N. (2006) The mTOR/PI3K and MAPK pathways converge on eIF4B to control its phosphorylation and activity. EMBO J. 25, 2781-2791. (Pubitemid 43980385)
78. Thiery, J.P. (2002) Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer 2, 442-454.
79. Yang, J. and Weinberg, R.A. (2008) Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev. Cell 14, 818-829. (Pubitemid 351757205)
80. Shipitsin, M., Campbell, L.L., Argani, P., Weremowicz, S., Bloushtain-Qimron, N., Yao, J., Nikolskaya, T., Serebryiskaya, T., Beroukhim, R., Hu, M., Halushka, M.K., Sukumar, S., Parker, L.M., Anderson, K.S., Harris, L.N., Garber, J.E., Richardson, A.L., Schnitt, S.J., Nikolsky, Y., Gelman, R.S., and Polyak, K. (2007) Molecular definition of breast tumor heterogeneity. Cancer Cell 11, 259-273. (Pubitemid 46349843)
81. Mani, S.A., Guo, W., Liao, M.J., Eaton, E.N., Ayyanan, A., Zhou, A.Y., Brooks, M., Reinhard, F., Zhang, C.C., Shipitsin, M., Campbell, L.L., Polyak, K., Brisken, C., Yang, J., and Weinberg, R.A. (2008) The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133, 704-715. (Pubitemid 351636299)
82. Ahmed, A.A., Etemadmoghadam, D., Temple, J., Lynch, A.G., Riad, M., Sharma, R., Stewart, C., Fereday, S., Caldas, C., Defazio, A., Bowtell, D., and Brenton, J.D. (2010) Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary. J. Pathol. 221, 49-56.
83. Scully, R. and Livingston, D.M. (2000) In search of the tumour-suppressor functions of BRCA1 and BRCA2. Nature 408, 429-432.
84. Samimi, G., Fink, D., Varki, N.M., Husain, A., Hoskins, W.J., Alberts, D.S., and Howell, S.B. (2000) Analysis of MLH1 and MSH2 expression in ovarian cancer before and after platinum drug-based chemotherapy. Clin. Cancer Res. 6, 1415-1421. (Pubitemid 30226229)
85. Balmaña, J., Stockwell, D.H., Steyerberg, E.W., Stoffel, E.M., Deffenbaugh, A.M., Reid, J.E., Ward, B., Scholl, T., Hendrickson, B., Tazelaar, J., Burbidge, L.A., and Syngal, S. (2006) Prediction of MLH1 and MSH2 mutations in Lynch syndrome. JAMA 296, 1469-1478. (Pubitemid 44465511)
86. South, S.A., Vance, H., Farrell, C., DiCioccio, RA, Fahey, C., Piver, M.S., and Rodabaugh, K.J. (2009) Consideration of hereditary nonpolyposis colorectal cancer in BRCA mutation-negative familial ovarian cancers. Cancer 115, 324-333.
87. Fleming, J.S., Beaugié, C.R., Haviv, I., Chenevix-Trench, G., and Tan, O.L. (2006) Incessant ovulation, inflammation and epithelial ovarian carcinogenesis: revisiting old hypotheses. Mol. Cell. Endocrinol. 247, 4-21. (Pubitemid 43277703)
88. Zorn, K.K., Bonome, T., Gangi, L., Chandramouli, G.V., Awtrey, C.S., Gardner, G.J., Barrett, J.C., Boyd, J., and Birrer, M.J. (2005) Gene expression profiles of serous, endometrioid, and clear cell subtypes of ovarian and endometrial cancer. Clin. Cancer Res. 11, 6422-6430. (Pubitemid 41338978)
89. Bonome, T., Lee, J.Y., Park, D.C., Radonovich, M., Pise-Masison, C., Brady, J., Gardner, G.J., Hao, K., Wong, W.H., Barrett, J.C., Lu, K.H., Sood, A.K., Gershenson, D.M., Mok, S.C., and Birrer, M.J. (2005) Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the ovary. Cancer Res. 65, 10602-10612. (Pubitemid 41743756)
90. Marchini, S., Mariani, P., Chiorino, G., Marrazzo, E., Bonomi, R., Fruscio, R., Clivio, L., Garbi, A., Torri, V., Cinquini, M., Dell'Anna, T., Apolone, G., Broggini, M., and D'Incalci, M. (2008) Analysis of gene expression in early-stage ovarian cancer. Clin. Cancer Res. 14, 7850-7860.
91. Iorio, M.V., Visone, R., Di Leva, G., Donati, V., Petrocca, F., Casalini, P., Taccioli, C., Volinia, S., Liu, C.G., Alder, H., Calin, G.A., Ménard, S., and Croce, C.M. (2007) MicroRNA signatures in human ovarian cancer. Cancer Res. 67, 8699-8707. (Pubitemid 47437445)
92. Veras, E., Mao, T.L., Ayhan, A., Ueda, S., Lai, H., Hayran, M., Shih, I.M., and Kurman, R.J. (2009) Cystic and adenofibromatous clear cell carcinomas of the ovary: distinctive tumors that differ in their pathogenesis and behavior: a clinicopathologic analysis of 122 cases. Am. J. Surg. Pathol. 33, 844-853.
93. Tothill, R.W., Tinker, A.V., George, J., Brown, R., Fox, S.B., Lade, S., Johnson, D.S., Trivett, M.K., Etemadmoghadam, D., Locandro, B., Traficante, N., Fereday, S., Hung, J.A., Chiew, Y.E., Haviv, I.; Australian Ovarian Cancer Study Group, Gertig, D., DeFazio, A., and Bowtell, D.D. (2008) Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome. Clin. Cancer Res. 14, 5198-5208.
94. Farley, J., Ozbun, L.L., and Birrer, M.J. (2008) Genomic analysis of epithelial ovarian cancer. Cell Res. 18, 538-548. (Pubitemid 351630950)
95. Bjerkvig, R., Tysnes, B.B., Aboody, K.S., Najbauer, J., and Terzis, A.J. (2005) Opinion: the origin of the cancer stem cell: current controversies and new insights. Nat. Rev. Cancer 5, 899-904. (Pubitemid 41746034)
96. Dittmar, T., Nagler, C., Schwitalla, S., Reith, G., Niggemann, B., and Zänker, K.S. (2009) Recurrence cancer stem cells - made by cell fusion? Med. Hypotheses 73, 542-547.
97. Dittmar, T., Schwitalla, S., Seidel, J., Haverkampf, S., Reith, G., Meyer-Staeckling, S., Brandt, B.H., Niggemann, B., and Zänker, K.S. (2011) Characterization of hybrid cells derived from spontaneous fusion events between breast epithelial cells exhibiting stem-like characteristics and breast cancer cells. Clin. Exp. Metastasis 28, 75-90.
98. Hubbard, S.A. and Gargett, C.E. (2010) A cancer stem cell origin for human endometrial carcinoma? Reproduction 140, 23-32.
99. Wu, X.Z. (2008) Origin of cancer stem cells: the role of self-renewal and differentiation. Ann. Surg. Oncol. 15, 407-414.
100. Kim, B.H., Sung, S.R., Choi, E.H., Kim, Y.I., Kim, K.J., Dong, S.H., Kim, H.J., Chang, Y.W., Lee, J.I., and Chang, R. (2000) Dedifferentiation of conditionally immortalized hepatocytes with long-term in vitro passage. Exp. Mol. Med. 32, 29-37.
101. Wu, X.Z., Chen, D., and Xie, G.R. (2006) Extracellular matrix remodeling in hepatocellular carcinoma: effects of soil on seed? Med. Hypotheses 66, 1115-1120.
102. Risch, H.A., McLaughlin, J.R., Cole, D.E., Rosen, B., Bradley, L., Fan, I., Tang, J., Li, S., Zhang, S., Shaw, P.A., and Narod, S.A. (2066) Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada. J. Natl. Cancer Inst. 98, 1694-1706.
103. Finch, A., Shaw, P., Rosen, B., Murphy, J., Narod, S.A., and Colgan, T.J. (2006) Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers. Gynecol. Oncol. 100, 58-64. (Pubitemid 41815050)
104. Kindelberger, D.W., Lee, Y., Miron, A., Hirsch, M.S., Feltmate, C., Medeiros, F., Callahan, M.J., Garner, E.O., Gordon, R.W., Birch, C., Berkowitz, R.S., Muto, MG., and Crum, C.P. (2007) Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship. Am. J. Surg. Pathol. 31, 161-169. (Pubitemid 46175016)
105. Lee, Y., Miron, A., Drapkin, R., Nucci, M.R., Medeiros, F., Saleemuddin, A., Garber, J., Birch, C., Mou, H., Gordon, R.W., Cramer, D.W., McKeon, F.D., and Crum, C.P. (2007) A candidate precursor to serous carcinoma that originates in the distal fallopian tube. J. Pathol. 211, 26-35. (Pubitemid 46092026)
106. Folkins, A.K., Jarboe, E.A., Saleemuddin, A., Lee, Y., Callahan, M.J., Drapkin, R., Garber, J.E., Muto, M.G., Tworoger, S., and Crum, C.P. (2008) A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations. Gynecol. Oncol. 109, 168-173.
107. Levanon, K., Crum, C., and Drapkin, R. (2008) New insights into the pathogenesis of serous ovarian cancer and its clinical impact. J. Clin. Oncol. 26, 5284-5293.
108. Saleemuddin, A., Folkins, A.K., Garrett, L., Garber, J., Muto, M.G., Crum, C.P., and Tworoger, S. (2008) Risk factors for a serous cancer precursor ("p53 signature") in women with inherited BRCA mutations. Gynecol. Oncol. 111, 226-232.
109. Josso, N., di Clemente, N., and Gouédard, L. (2001) Anti-Müllerian hormone and its receptors. Mol. Cell. Endocrinol. 179, 25-32.
110. Klattig, J. and Englert, C. (2007) The Müllerian duct: recent insights into its development and regression. Sex. Dev. 1, 271-278. (Pubitemid 350136531)
111. Altaras, M.M., Aviram, R., Cohen, I., Cordoba, M., Weiss, E., and Beyth, Y. (1991) Primary peritoneal papillary serous adenocarcinoma: clinical and management aspects. Gynecol. Oncol. 40, 230-236.
112. Fromm, G.L., Gershenson, D.M., and Silva, E.G. (1990) Papillary serous carcinoma of the peritoneum. Obstet. Gynecol. 75, 89-95. (Pubitemid 20047939)
113. Altaras, M.M., Bernheim, J., Zehavi, T., Drucker, L., Uziel, O., and Fishman, A. (2002) Papillary serous carcinoma of the peritoneum coexisting with or after endometrial carcinoma. Gynecol. Oncol. 84, 245-251. (Pubitemid 34136775)
114. Casey, M.J. and Bewtra, C. (2004) Peritoneal carcinoma in women with genetic susceptibility: implications for Jewish populations. Fam. Cancer 3, 265-281.
115. Finch, A., Beiner, M., Lubinski, J., Lynch, H.T., Moller, P., Rosen, B., Murphy, J., Ghadirian, P., Friedman, E., Foulkes, W.D., Kim-Sing, C., Wagner, T., Tung, N., Couch, F., Stoppa-Lyonnet, D., Ainsworth, P., Daly, M., Pasini, B., Gershoni-Baruch, R., Eng, C., Olopade, O.I., McLennan, J., Karlan, B., Weitzel, J., Sun, P., and Narod, S.A; Hereditary Ovarian Cancer Clinical Study Group (2006) Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation. JAMA 296, 185-192.
116. Olivier, R.I., van Beurden, M., Lubsen, M.A., Rookus, M.A., Mooij, T.M., van de Vijver, M.J., and van't Veer, L.J. (2004) Clinical outcome of prophylactic oophorectomy in BRCA1/BRCA2 mutation carriers and events during followup. Br. J. Cancer 90, 1492-1497.
117. Cheng, W., Liu, J., Yoshida, H., Rosen, D., and Naora, H. (2005) Lineage infidelity of epithelial ovarian cancers is controlled by HOX genes that specify regional identity in the reproductive tract. Nat. Med. 11, 531-537. (Pubitemid 40685976)
118. Lauchlan, S.C. (1994) The secondary müllerian system revisited. Int. J. Gynecol. Pathol. 13, 73-79.
119. Chan, R.W., Schwab, K.E., and Gargett, C.E. (2004) Clonogenicity of human endometrial epithelial and stromal cells. Biol. Reprod. 70, 1738-1750. (Pubitemid 38715630)
120. Cervelló, I., Martínez-Conejero, J.A., Horcajadas, J.A., Pellicer,A., and Simón, C. (2007) Identification, characterization and co-localization of label-retaining cell population in mouse endometrium with typical undifferentiated markers. Hum. Reprod. 22, 45-51.
121. Gargett, C.E., Chan, R.W., and Schwab, K.E. (2007) Endometrial stem cells. Curr. Opin. Obstet. Gynecol. 19, 377-383. (Pubitemid 47067103)
122. Meng, X., Ichim, T.E., Zhong, J., Rogers, A., Yin, Z., Jackson, J., Wang, H., Ge, W., Bogin, V., Chan, K.W., Thébaud, B., and Riordan, N.H. (2007) Endometrial regenerative cells: a novel stem cell population. J. Transl. Med. 5, 57.
123. Wolff, E.F., Wolff, A.B., Hongling Du., and Taylor, H.S. (2007) Demonstration of multipotent stem cells in the adult human endometrium by in vitro chondrogenesis. Reprod. Sci. 14, 524-533. (Pubitemid 351168784)
124. Schwab, K.E., Hutchinson, P., and Gargett, C.E. (2008) Identification of surface markers for prospective isolation of human endometrial stromal colony-forming cells. Hum. Reprod. 23, 934-943.
125. Jazedje, T., Perin, P.M., Czeresnia, C.E., Maluf, M., Halpern, S., Secco, M., Bueno, D.F., Vieira, N.M., Zucconi, E., and Zatz, M. (2009) Human fallopian tube: a new source of multipotent adult mesenchymal stem cells discarded in surgical procedures. J. Transl. Med. 7, 46.
126. Bowen, N.J., Walker, L.D., Matyunina, L.V., Logani, S., Totten, K.A., Benigno, B.B., and McDonald, J.F. (2009) Gene expression profiling supports the hypothesis that human ovarian surface epithelia are multipotent and capable of serving as ovarian cancer initiating cells. BMC Med. Genomics 29, 71.
127. Bapat, S.A. (2010) Human ovarian cancer stem cells. Reproduction 140, 33-41.
128. Bapat, S.A., Mali, A.M., Koppikar, C.B., and Kurrey, N.K. (2005) Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer. Cancer Res. 65, 3025-3029. (Pubitemid 40524578)
129. Shmelkov, S.V., Butler, J.M., Hooper, A.T., Hormigo, A., Kushner, J., Milde, T., St Clair, R., Baljevic, M., White, I., Jin, D.K., Chadburn, A., Murphy, A.J., Valenzuela, D.M., Gale, N.W., Thurston, G., Yancopoulos, G.D., D'Angelica, M., Kemeny, N., Lyden, D., and Rafii, S. (2008) CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors. J. Clin. Invest. 118, 2111-2120. (Pubitemid 351872330)
130. Guo, R., Wu, Q., Liu, F., and Wang, Y. (2011) Description of the CD133+ subpopulation of the human ovarian cancer cell line OVCAR3. Oncol. Rep. 25, 141-146.
131. Baba, T., Convery, P.A., Matsumura, N., Whitaker, R.S., Kondoh, E., Perry, T., Huang, Z., Bentley, R.C., Mori, S., Fujii, S., Marks, J.R., Berchuck, A., and Murphy, S.K. (2009) Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells. Oncogene 28, 209-218.
132. Peng, S., Maihle, N.J., and Huang, Y. (2010) Pluripotency factors Lin28 and Oct4 identify a sub-population of stem celllike cells in ovarian cancer. Oncogene 29, 2153-2159.
133. Goodell, M.A., Brose, K., Paradis, G., Conner, A.S., and Mulligan, R.C. (1996) Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J. Exp. Med. 183, 1797-1806. (Pubitemid 26134320)
134. Lin, K.K. and Goodell, M.A. (2006) Purification of hematopoietic stem cells using the side population. Methods Enzymol. 420, 255-264. (Pubitemid 44855867)
135. Alvi, A.J., Clayton, H., Joshi, C., Enver, T., Ashworth, A., Vivanco, M.M., Dale, T.C., and Smalley, M.J. (2003) Functional and molecular characterisation of mammary side population cells. Breast Cancer Res. 5, R1-8.
136. Ambler, C.A. and Maatta, A. (2009) Epidermal stem cells: location, potential and contribution to cancer. J. Pathol. 217, 206-216.
137. Gao, Q., Geng, L., Kvalheim, G., Gaudernack, G., and Suo, Z. (2009) Identification of cancer stem-like side population cells in ovarian cancer cell line OVCAR-3. Ultrastruct. Pathol. 33, 175-181.
138. Moshaver, B., van Rhenen, A., Kelder, A., van der Pol, M., Terwijn, M., Bachas, C., Westra, A.H., Ossenkoppele, G.J., Zweegman, S., and Schuurhuis, G.J. (2008) Identification of a small subpopulation of candidate leukemia-initiating cells in the side population of patients with acute myeloid leukemia. Stem Cells 26, 3059-3067.
139. Engelmann, K., Shen, H., and Finn, O.J. (2008) MCF7 side population cells with characteristics of cancer stem/progenitor cells express the tumor antigen MUC1. Cancer Res. 68, 2419-2426. (Pubitemid 351521817)
140. Hu, L., McArthur, C., and Jaffe, R.B. (2010) Ovarian cancer stem-like side-population cells are tumourigenic and chemoresistant. Br. J. Cancer 102, 1276-1283.
141. Moserle, L., Indraccolo, S., Ghisi, M., Frasson, C., Fortunato, E., Canevari, S., Miotti, S., Tosello, V., Zamarchi, R., Corradin, A., Minuzzo, S., Rossi, E., Basso, G., and Amadori, A. (2008) The side population of ovarian cancer cells is a primary target of IFN-alpha antitumor effects. Cancer Res. 68, 5658-5668.
142. Zhang, H.B., Ren, C.P., Yang, X.Y., Wang, L., Li, H., Zhao, M., Yang, H., and Yao, K.T. (2007) Identification of label-retaining cells in nasopharyngeal epithelia and nasopharyngeal carcinoma tissues. Histochem. Cell Biol. 127, 347-354.
143. Tang, D.G., Patrawala, L., Calhoun, T., Bhatia, B., Choy, G., Schneider-Broussard, R., and Jeter, C. (2007) Prostate cancer stem/progenitor cells: identification, characterization, and implications. Mol. Carcinog. 46, 1-14. (Pubitemid 46095228)
144. Zabierowski, S.E. and Herlyn, M. (2008) Melanoma stem cells: the dark seed of melanoma. J. Clin. Oncol. 26, 2890-2894.
145. Fillmore, C.M. and Kuperwasser, C. (2008) Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy. Breast Cancer Res. 10, R25.
146. Kuwahara, R., Kofman, A.V., Landis, C.S., Swenson, E.S., Barendswaard, E., and Theise, N.D. (2008) The hepatic stem cell niche: identification by label-retaining cell assay. Hepatology 47, 1994-2002. (Pubitemid 351945566)
147. Jennifer, L., Dembinski, L., and Krauss, S. (2010) Distinct slow-cycling cancer stem-like subpopulation of pancreatic adenocarcinoma cells is maintained in vivo. Cancers, 2, 2011-2025.
148. Kusumbe, A.P. and Bapat, S.A. (2009) Cancer stem cells and aneuploid populations within developing tumors are the major determinants of tumor dormancy. Cancer Res. 69(24), 9245-9253.
149. Ross, H.H., Levkoff, L.H., Marshall, G.P., 2nd, Caldeira, M., Steindler, D.A., Reynolds, B.A., and Laywell, E.D. (2008) Bromodeoxyuridine induces senescence in neural stem and progenitor cells. Stem Cells 26, 3218-3227.
150. Lanzkron, S.M., Collector, M.I., and Sharkis, S.J. (1999) Hematopoietic stem cell tracking in vivo: a comparison of short-term and long-term repopulating cells. Blood 93, 1916-1921. (Pubitemid 29128493)
151. Boutonnat, J., Faussat, A.M., Marie, J.P., Bignon, J., Wdzieczak-Bakala, J., Barbier, M., Thierry, J., Ronot, X., and Colle, P.E. (2005) Usefulness of PKH fluorescent labelling to study leukemic cell proliferation with various cytostatic drugs or acetyl tetrapeptide-AcSDKP. BMC Cancer 5, 120.
152. Nusse, R. (2005) Wnt signaling in disease and in development. Cell Res. 15, 28-32.
153. Reya, T. and Clevers, H. (2005) Wnt signalling in stem cells and cancer. Nature 434, 349-354.
154. Vainio, S., Heikkilä, M., Kispert, A., Chin, N., and McMahon, A.P. (1999) Female development in mammals is regulated by Wnt-4 signaling. Nature 397, 405-409.
155. Yao, H.H., Matzuk, M.M., Jorgez, C.J., Menke, D.B., Page, D.C., Swain, A., and Capel, B. (2004) Follistatin operates downstream of Wnt4 in mammalian ovary organogenesis. Dev. Dyn. 230, 210-215. (Pubitemid 38669583)
156. Inoki, K., Ouyang, H., Zhu, T., Lindvall, C., Wang, Y., Zhang, X., Yang, Q., Bennett, C., Harada, Y., Stankunas, K., Wang, C.Y., He, X., MacDougald, O.A., You, M., Williams, B.O., and Guan, K.L. (2006) TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth. Cell 126, 955-968. (Pubitemid 44310775)
157. Chassot, A.A., Ranc, F., Gregoire, E.P., Roepers-Gajadien, H.L., Taketo, M.M., Camerino, G., de Rooij, D.G., Schedl, A., and Chabiossier, M.C. (2008) Activation of beta-catenin signaling by Rspo1 controls differentiation of the mammalian ovary. Hum. Mol. Genet. 17, 1264-1277. (Pubitemid 351566963)
158. Gamallo, C., Palacios, J., Moreno, G., Calvo de Mora, J., Suarez, A., and Armas, A. (1999) Beta-catenin expression pattern in stage I and II ovarian carcinomas: relationship with beta-catenin gene mutations, clinicopathological features, and clinical outcome. Am. J. Pathol. 155, 527-536. (Pubitemid 29370402)
159. Wright, K., Wilson, P., Morland, S., Campbell, I., Walsh, M., Hurst, T., Ward, B., Cummings, M., and Chenevix-Trench, G. (1999) beta-Catenin mutation and expression analysis in ovarian cancer: exon 3 mutations and nuclear translocation in 16% of endometrioid tumours. Int. J. Cancer 82, 625-629. (Pubitemid 29356957)
160. Rask, K., Nilsson, A., Brännström, M., Carlsson, P., Hellberg, P., Janson, P.O., Hedin, L., and Sundfeldt, K. (2003) Wnt-signalling pathway in ovarian epithelial tumours: increased expression of beta-catenin and GSK3beta. Br. J. Cancer 89, 1298-1304. (Pubitemid 37363420)
161. Takada, T., Yagi, Y., Maekita, T., Imura, M., Nakagawa, S., Tsao, S.W., Miyamoto, K., Yoshino, O., Yasugi, T., Taketani, Y., and Ushijima, T. (2004) Methylation-associated silencing of the Wnt antagonist SFRP1 gene in human ovarian cancers. Cancer Sci. 95, 741-744. (Pubitemid 39335094)
162. Wu, R., Hendrix-Lucas, N., Kuick, R., Zhai, Y., Schwartz, D.R., Akyol, A., Hanash, S., Misek, D.E., Katabuchi, H., Williams, B.O., Fearon, E.R., and Cho, K.R. (2007) Mouse model of human ovarian endometrioid adenocarcinoma based on somatic defects in the Wnt/beta-catenin and PI3K/Pten signaling pathways. Cancer Cell 11, 321-333.
163. Goode, E.L., Szabo, C., Prokunina-Olsson, L., Vierkant, R.A., Fredericksen, Z.S., Collins, F.S., White, K.L., Schmidt, M., Fridley B.L., and Couch, F.J. (2009) No association between a candidate TCF7L2 variant and risk of breast or ovarian cancer. BMC Cancer 9, 312.
164. Saegusa, M. and Okayasu, I. (2001) Frequent nuclear beta-catenin accumulation and associated mutations in endometrioid-type endometrial and ovarian carcinomas with squamous differentiation. J. Pathol. 194, 59-67.
165. Schwartz, D.R., Wu, R., Kardia, S.L.R., Levin, A.M., Huang, C.C., Shedden, K., Kuick, R., Misek, D., Hanash, S., Taylor, J.M.G., Reed, H., Hendrix, N., Zhai, Y., Fearon, E.R., and Cho, K.R. (2003) Novel candidate targets of β-catenin/TCF signalling identified by gene expression of ovarian endometrioid adenocarcinomas. Cancer Res. 63, 2913-2922.
166. Menendez, L., Walker, D., Matyunina, L.V., Dickerson, E.B., Bowen, N.J., Polavarapu, N., Benigno, B.B., and McDonald, J.F. (2007) Identification of candidate methylation-responsive genes in ovarian cancer. Mol. Cancer 6, 10.
167. Hendrix, N., Wu, R., Kuick, R., Schwartz, D.R., Fearon, E.R., and Cho, K.R. (2006) FGF9 has oncogenic activity and is a downstream target of Wnt signaling ovarian endometrioid adenocarcinomas. Cancer Res. 66, 1354-1362.
168. Faleiro-Rodrigues, C., Macedo-Pinto, I., Pereira, D., and Lopes, C.S. (2004) Loss of beta-catenin is associated with poor survival in ovarian carcinomas Int. J. Gynecol. Pathol. 23, 337-346. (Pubitemid 39299022)
169. Rosen, D.G., Zhang, Z., Chang, B., Wang, X., Lin, E., and Liu, J. (2010) Low membranous expression of b-catenin and high mitotic count predict poor prognosis in endometrioid carcinoma of the ovary. Mod. Pathol. 23, 113-122.
170. Clark, A.M., Garland, K.K., and Russell, L.D. (2000) Desert hedgehog (Dhh) gene is required in the mouse testis for formation of adult-type Leydig cells and normal development of peritubular cells and seminiferous tubules. Biol. Reprod. 63, 1825-1838.
171. Chiang, C., Litingtung, Y., Harris, M.P., Simandl, B.K., Li, Y., Beachy, P.A., and Fallon, J.F. (2001) Manifestation of the limb prepattern: limb development in the absence of sonic hedgehog function. Dev. Biol. 236, 421-435. (Pubitemid 32756995)
172. Weedon, M.N., Lango, H., Lindgren, C.M., Wallace, C., Evans, D.M., Mangino, M., Freathy, R.M., Perry, J.R., Stevens, S., Hall, A.S., Samani, N.J., Shields, B., Prokopenko, I., Farrall, M., Dominiczak, A; Diabetes Genetics Initiative; Wellcome Trust Case Control Consortium, Johnson, T., Bergmann, S., Beckmann, J.S., Vollenweider, P., Waterworth, D.M., Mooser, V., Palmer, C.N., Morris, A.D., Ouwehand, W.H.; Cambridge GEM Consortium, Zhao, J.H., Li, S., Loos, R.J., Barroso, I., Deloukas, P., Sandhu, M.S., Wheeler, E., Soranzo, N., Inouye, M., Wareham, N.J., Caulfield, M., Munroe, P.B., Hattersley, A.T., McCarthy, M.I., and Frayling, T.M. (2008) Genome-wide association analysis identifies 20 loci that influence adult height. Nat. Genet. 40, 575-583 (Pubitemid 351601210)
173. Sekiya, I., Vuoristo, J.T., Larson, B.L., and Prockop, D.J. (2002) In vitro cartilage formation by human adult stem cells from bone marrow stroma defines the sequence of cellular and molecular events during chondrogenesis. Proc. Natl. Acad. Sci. U. S. A. 99, 4397-4402. (Pubitemid 34285996)
174. Karhadkar, S.S., Bova, G.S., Abdallah, N., Dhara, S., Gardner, D., Maitra, A., Isaacs, J.T., Berman, D.M., and Beachy, P.A. (2004) Hedgehog signalling in prostate regeneration, neoplasia and metastasis. Nature 431, 707-712. (Pubitemid 39382619)
175. Silva-Vargas, V., Lo Celso, C., Giangreco, A., Ofstad, T., Prowse, D.M., Braun, K.M, and Watt, F.M. (2005) Beta-catenin and Hedgehog signal strength can specify number and location of hair follicles in adult epidermis without recruitment of bulge stem cells. Dev. Cell 9, 121-131. (Pubitemid 40903665)
176. Ahn, S. and Joyner, A.L. (2005) In vivo analysis of quiescent adult neural stem cells responding to Sonic hedgehog. Nature 437, 894-897. (Pubitemid 41486765)
177. Liu, S., Dontu, G., Mantle, I.D., Patel, S., Ahn, N.S., Jackson, K.W., Suri, P., and Wicha, M.S. (2006) Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. Cancer Res. 66, 6063-6071.
178. Ogden, S.K., Ascano, M.J., Stegman, M.A., and Robbins, D.J. (2004) Regulation of Hedgehog signalling: a complex story. Biochem. Pharmacol. 67, 805-814. (Pubitemid 38201626)
179. Taipale, J. and Beachy, P.A. (2001) The Hedgehog and Wnt signalling pathways in cancer. Nature 411, 349-354. (Pubitemid 32467044)
180. Ehtesham, M., Sarangi, A., and Valadez, J.G., Chanthaphaychith, S., Becher, M.W., Abel, T.W., Thompson, R.C., and Cooper, M.K. (2007) Ligand-dependent activation of the hedgehog pathway in glioma progenitor cells. Oncogene 26, 5752-5761. (Pubitemid 47312811)
181. Berman, D.M., Karhadkar, S.S., Maitra, A., Montes De Oca, R., Gerstenblith, M.R., Briggs, K., Parker, A.R., Shimada, Y., Eshleman, J.R., Watkins, D.N., and Beachy, P.A. (2003) Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumors. Nature 425, 846-851. (Pubitemid 37351469)
182. Ohta, M., Tateishi, K., Kanai, F., Watabe, H., Kondo, S., Guleng, B., Tanaka, Y., Asaoka, Y., Jazag, A., Imamura, J., Ijichi, H., Ikenoue, T., Sata, M., Miyagishi, M., Taira, K., Tada, M., Kawabe, T., and Omata, M. (2005) p53- Independent negative regulation of p21/cyclin-dependent kinase-interacting protein 1 by the sonic hedgehog-glioma-associated oncogene 1 pathway in gastric carcinoma cells. Cancer Res. 65, 10822-10829. (Pubitemid 41713349)
183. Tsuda, N., Ishiyama, S., Li, Y., Ioannides, C.G., Abbruzzese, J.L., and Chang, D.Z. (2006) Synthetic microRNA designed to target glioma-associated antigen 1 transcription factor inhibits division and induces late apoptosis in pancreatic tumor cells. Clin. Cancer Res. 12, 6557-6564. (Pubitemid 44799731)
184. Pasca di Magliano, M., Sekine, S., Ermilov, A., Ferris, J., Dlugosz, A.A., and Hebrok, M. (2006) Hedgehog/Ras interactions regulate early stages of pancreatic cancer. Genes Dev. 20, 3161-3173. (Pubitemid 44790630)
185. Mukherjee, S., Frolova, N., Sadlonova, A., Novak, Z., Steg, A., Page, G.P., Welch, D.R., Lobo-Ruppert, S.M., Ruppert, J.M., Johnson, M.R., and Frost, A.R. (2006) Hedgehog signaling and response to cyclopamine differ in epithelial and stromal cells in benign breast and breast cancer. Cancer Biol. Ther. 5, 674-683. (Pubitemid 44024723)
186. Liao, X., Siu, M.K., Au, C.W., Wong, E.S., Chan, H.Y., Ip, P.P., Ngan, H.Y., and Cheung, A.N. (2009) Aberrant activation of hedgehog signaling pathway in ovarian cancers: effect on prognosis, cell invasion and differentiation. Carcinogenesis 30, 131-140.
187. Bhattacharya, R., Kwon, J., Ali, B., Wang, E., Patra, S., Shridhar, V., and Mukherjee, P. (2008) Role of hedgehog signaling in ovarian cancer. Clin. Cancer Res. 14, 7659-7666.
188. Chen, X., Horiuchi, A., Kikuchi, N., Osada, R., Yoshida, J., Shiozawa, T., and Konishi, I. (2007) Hedgehog signal pathway is activated in ovarian carcinomas, correlating with cell proliferation: it's inhibition leads to growth suppression and apoptosis. Cancer Sci. 98, 68-76. (Pubitemid 44803922)
189. Sanchez, P., Hernandez, A.M., Stecca, B., Kahler, A.J., DeGueme, A.M., Barrett, A., Beyna, M., Datta, M.W., Datta, S., Ruiz, and Altaba, A. (2004) Inhibition of prostate cancer proliferation by interference with Sonic hedgehog-Gli1 signaling. Proc. Natl. Acad. Sci. U. S. A. 101, 12561-12566. (Pubitemid 39122063)
190. Lauth, M., Bergstrom, A., Shimokawa, T., and Toftgard, R. (2007) Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists. Proc. Natl. Acad. Sci. U. S. A. 104, 8455-8460. (Pubitemid 47175509)
191. Rubin, L.L. and de Sauvage, F.J. (2006) Targeting the Hedgehog pathway in cancer. Nat. Rev. Drug Discov. 5, 1026-1033. (Pubitemid 44835129)
192. Yang, L., He, J., Huang, S., Zhang, X., Bian, Y., He, N., Zhang, H., and Xie, J. (2009) Activation of hedgehog signaling is not a frequent event in ovarian cancers. Mol. Cancer 8, 112.
193. Yauch, R.L., Gould, S.E., Scales, S.J., Tang, T., Tian, H., Ahn, C.P., Marshall, D., Fu, L., Januario, T., Kallop, D., Nannini-Pepe, M., Kotkow, K., Marsters, J.C., Rubin, L.L., and de Sauvage, F.J. (2008) A paracrine requirement for hedgehog signalling in cancer. Nature 455, 406-410.
194. Porter, J.A., von Kessler, D.P., Ekker, S.C., Young, K.E., Lee, J.J., Moses, K., and Beachy, P.A. (1995) The product of hedgehog autoproteolytic cleavage active in local and long-range signaling. Nature 374, 363-366.
195. Evangelista,M., Tian, H., and de Sauvage F.J. (2006) The hedgehog signaling pathway in cancer. Clin. Cancer Res. 12, 5924-5928. (Pubitemid 44703749)
196. Steg, A., Wang, W., Blanquicett, C., Grunda, J.M., Eltoum, I.A., Wang, K., Buchsbaum, D.J., Vickers, S.M., Russo, S., Diasio, R.B., Frost, A.R., LoBuglio, A.F., Grizzle, W.E., and Johnson, M.R. (2006) Multiple gene expression analyses in paraffin-embedded tissues by TaqMan low-density array: application to hedgehog and Wnt pathway analysis in ovarian endometrioid adenocarcinoma. J. Mol. Diagn. 8, 76-83. (Pubitemid 43257437)
197. Ponnusamy, M.P. and Batra, S.K. (2008) Ovarian cancer: emerging concept on cancer stem cells. J. Ovar. Res. 1, 4.
198. Artavanis-Tsakonas, S., Rand, M.D., and Lake, R.J. (1999) Notch signaling: cell fate control and signal integration in development. Science 284, 770-776. (Pubitemid 29291335)
199. Davis, R.L. and Turner, D.L. (2001) Vertebrate hairy and Enhancer of split related proteins: transcriptional repressors regulating cellular differentiation and embryonic patterning. Oncogene 20, 8342-8357 (Pubitemid 34121905)
200. Lawson, N.D., Scheer, N., Pham, V.N., Kim, C.H., Chitnis, A.B., Campos-Ortega, J.A., and Weinstein, B.M. (2001) Notch signaling is required for arterial-venous differentiation during embryonic vascular development. Development 128, 3675-3683. (Pubitemid 32998917)
201. Hitoshi, S., Alexson, T., Tropepe, V., Donoviel, D., Elia, A.J., Nye, J.S., Conlon, R.A., Mak, T.W., Bernstein, A., and van der Kooy, D. (2002) Notch pathway molecules are essential for the maintenance, but not the generation, of mammalian neural stem cells. Genes Dev. 16, 846-858. (Pubitemid 34280108)
202. Reynaud-Deonauth, S., Zhang, H., Afouda, A., Taillefert, S., Beatus, P., Kloc, M., Etkin, L.D., Fischer-Lougheed, J., and Spohr, G. (2002) Notch signaling is involved in the regulation of Id3 gene transcription during Xenopus embryogenesis. Differentiation 69, 198-208.
203. Androutsellis-Theotokis, A., Leker, R.R., Soldner, F., Hoeppner, D.J., Ravin, R., Poser, S.W., Rueger, M.A., Bae, S.K., Kittappa, R., and McKay, R.D. (2006) Notch signalling regulates stem cell numbers in vitro and in vivo. Nature 442, 823-826.
204. Dontu, G., Jackson, K.W., McNicholas, E., Kawamura, M.J., Abdallah, W.M., and Wicha, M.S. (2004) Role of notch signaling in cell-fate determination of human mammary stem/progenitor cells. Breast Cancer Res. 6, R605-615.
205. Zwahlen, D., Tschan, M.P., Grob, T.J., Peters, U.R., Fink, D., Haenggi, W., Altermatt, H.J., Cajot, J.F., Tobler, A., Fey, M.F., and Aebi, S. (2000) Differential expression of p73 splice variants and protein in benign and malignant ovarian tumours. Int. J. Cancer 88, 66-70.
206. Sasaki, Y., Ishida, S., Morimoto, I., Yamashita, T., Kojima, T., Kihara, C., Tanaka, T., Imai, K., Nakamura, Y., and Tokino, T. (2002) The p53 family member genes are involved in the Notch signal pathway. J. Biol. Chem. 277, 719-724. (Pubitemid 34952112)
207. Park, J.T., Li, M., Nakayama, K., Mao, T.L., Davidson, B., Zhang, Z., Kurman, R.J., Eberhart, C.G., Shih, I.M., and Wang, T.L. (2006) Notch3 gene amplification in ovarian cancer. Cancer Res. 66, 6312-6318.
208. Lu, K.H., Patterson, A.P., Wang, L., Marquez, R.T., Atkinson, E.N., Baggerly, K.A., Ramoth, L.R., Rosen, D.G., Liu, J., Hellstrom, I., Smith. D., Hartmann, L., Fishman, D., Berchuck, A., Schmandt, R., Whitaker, R., Gershenson, D.M., Mills, G.B., and Bast, R.C., Jr. (2004) Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis. Clin. Cancer Res. 10, 3291-3300. (Pubitemid 38685433)
209. Nakayama, K., Nakayama, N., Jinawath, N., Salani, R., Kurman, R.J., Shih, I.M., and Wang, T.L. (2007) Amplicon profiles in ovarian serous carcinomas. Int. J. Cancer 120, 2613-2617. (Pubitemid 46651282)
210. Jung, S.G., Kwon, Y.D., Song, J.A., Back, M.J., Lee, S.Y., Lee, C., Hwang, Y.Y., and An, H.J. (2010) Prognostic significance of Notch 3 gene expression in ovarian serous carcinoma. Cancer Sci. 101, 1977-1983.
211. Choi, J.H., Park, J.T., Davidson, B., Morin, P.J., Shih, I.M., and Wang, T.L. (2008) Jagged-1 and Notch3 juxtacrine loop regulates ovarian tumor growth and adhesion. Cancer Res. 68, 5716-5723.
212. Hopfer, O., Zwahlen, D., Fey, M.F., and Aebi, S. (2005) The Notch pathway in ovarian carcinomas and adenomas. Br. J. Cancer 93, 709-718. (Pubitemid 41486463)
213. Zhang, S., Balch, C., Chan, M.W., Lai, H.C., Matei, D., Schilder, J.M., Yan, P.S., Huang, T.H., Nephew, K.P., Zhang, S., Balch, C., Chan, M.W., Lai, H.C., Matei, D., Schilder, J.M., Yan, P.S., Huang, T.H., and Nephew, K.P. (2008) Identification and characterization of ovarian cancer-initiating cells from primary human tumors. Cancer Res. 68, 4311-4320.
214. Rose, S.L., Kunnimalaiyaan, M., Drenzek, J., and Seiler, N. (2010) Notch 1 signaling is active in ovarian cancer. Gynecol. Oncol. 117, 1130-1133.
215. Wang, M., Wu, L., Wang, L., and Xin, X. (2010) Down-regulation of Notch1 by gamma-secretase inhibition contributes to cell growth inhibition and apoptosis in ovarian cancer cells A2780. Biochem. Biophys. Res. Commun. 393, 144-149.
216. Thurston, G., and Kitajewski, J. (2008) VEGF and Delta-Notch: interacting signalling pathways in tumor angiogenesis. Br. J. Cancer 99, 1204-1209.
217. Patel, N.S., Li, J.L., Generali, D., Poulsom, R., Cranston. D.W., and Harris, A.L. (2005) Up-regulation of delta-like 4 ligand in human tumor vasculature and the role of basal expression in endothelial cell function. Cancer Res. 65, 8690-8697. (Pubitemid 41377356)
218. Li, J.-L., Sainson, R.C.A., Shi, W., Leek, R., Harrington, L.S., Preusser, M., Biswas, S., Turley, H., Heikamp, E., Hainfellner, J.A., and Harris, A.L. (2007) Delta-like 4 Notch 33 ligand regulates tumor angiogenesis, improves tumor vascular function, and promotes tumor growth in vivo. Cancer Res. 67, 11244-11253. (Pubitemid 350248550)
219. Lu, C., Bonome, T., Li, Y., Kamat, A.A., Han, L.Y., Schmandt, R., Coleman, R.L., Gershenson, D.M., Jaffe, R.B., Birrer, M.J., and Sood, A.K. (2007) Gene alterations identified by expression profiling in tumor-associated endothelial cells from invasive ovarian carcinoma. Cancer Res. 67, 1757-1768. (Pubitemid 46383403)
220. Gautam, A., Li, Z.R., and Bepler, G. (2003) RRM1-induced metastasis suppression through PTEN-regulated pathways. Oncogene 22, 2135-2142. (Pubitemid 36539563)
221. Puzio-Kuter, A.M., Castillo-Martin, M., Kinkade, C.W., Wang, X., Shen, T.H., Matos, T., Shen, M.M., Cordon-Cardo, C., and Abate-Shen, C. (2009) Inactivation of p53 and Pten promotes invasive bladder cancer. Genes Dev. 23, 675-680.
222. Nassif, N.T., Lobo, G.P., Wu, X., Henderson, C.J., Morrison, C.D., Eng, C., Jalaludin, B., and Segelov, E. (2004) PTEN mutations are common in sporadic microsatellite stable colorectal cancer. Oncogene 23, 617-628. (Pubitemid 38175018)
223. Khan, S., Kumagai, T., Vora, J., Bose, N., Sehgal, I., Koeffler, P.H., and Bose, S. (2004) PTEN promoter is methylated in a proportion of invasive breast cancers. Int. J. Cancer 112, 407-410. (Pubitemid 39390604)
224. Oki, E., Baba, H., Tokunaga, E., Nakamura, T., Ueda, N., Futatsugi, M., Mashino, K., Yamamoto, M., Ikebe, M., Kakeji, Y., and Maehara, Y. (2005) Akt phosphorylation associates with LOH of PTEN and leads to chemoresistance for gastric cancer. Int. J. Cancer 117, 376-380. (Pubitemid 41429560)
225. Nagata, Y., Lan, K.H., Zhou, X., Tan, M., Esteva, F.J., Sahin, A.A., Klos, K.S., Li, P., Monia, B.P., Nguyen, N.T., Hortobagyi, G.N., Hung, M.C., and Yu, D. (2004) PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients. Cancer Cell 6, 117-127. (Pubitemid 39485684)
226. Mackay, H.J., Gallinger, S., Tsao, M.S., McLachlin, C.M., Tu, D., Keiser, K., Eisenhauer, E.A., and Oza, A.M. (2010) Prognostic value of microsatellite instability (MSI) and PTEN expression in women with endometrial cancer: results from studies of the NCIC Clinical Trials Group (NCIC CTG). Eur. J. Cancer 46, 1365-1373.
227. Athanassiadou, P., Athanassiades, P., Grapsa, D., Gonidi, M., Athanassiadou, A.M., Stamati, P.N., and Patsouris, E. (2007) The prognostic value of PTEN, p53, and beta-catenin in endometrial carcinoma: a prospective immunocytochemical study. Int. J. Gynecol. Cancer 17, 697-704. (Pubitemid 46744009)
228. Yoo, L.I., Liu, D.W., Vu, S.L., Bronson, R.T., Wu, H., and Yuan, J. (2006) Pten deficiency activates distinct downstream signaling pathways in a tissue-specific manner. Cancer Res. 66, 1929-1939.
229. Hill, R. and Wu, H. (2009) PTEN, stem cells, and cancer stem cells. J. Biol. Chem. 284, 11755-11759.
230. Li, A.G., Piluso, L.G., Cai, X., Wei, G., Sellers, W.R., and Liu, X. (2006) Mechanistic insights into maintenance of high p53 acetylation by PTEN. Mol. Cell 23, 575-587. (Pubitemid 44205492)
231. Obata, K., Morland, S.J., Watson, R.H., Hitchcock, A., Chenevix-Trench, G., Thomas, E.J., and Campbell, I.G. (1998) Frequent PTEN/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors. Cancer Res. 58, 2095-2097. (Pubitemid 28232892)
232. Sato, N., Tsunoda, H., Nishida, M., Morishita, Y., Takimoto, Y., Kubo, T., and Noguchi, M. (2000) Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary. Cancer Res. 60, 7052-7056. (Pubitemid 32059184)
233. Schöndorf, T., Dostal, A., Grabmann, J., and Göhring, U.J. (2000) Single mutations of the PTEN gene in recurrent ovarian carcinomas. J. Soc. Gynecol. Investig. 7, 313-316.
234. Asselin, E., Mills, G.B., and Tsang, B.K. (2001) XIAP regulates Akt activity and caspase-3-dependent cleavage during cisplatin- induced apoptosis in human ovarian epithelial cancer cells. Cancer Res. 61, 1862-1868. (Pubitemid 32692000)
235. Fraser, M., Leung, B.M., Yan, X., Dan, H.C., Cheng, J.Q., and Tsang, B.K. (2003) p53 is a determinant of X-linked inhibitor of apoptosis protein/Akt-mediated chemoresistance in human ovarian cancer cells. Cancer Res. 63, 7081-7088. (Pubitemid 37413443)
236. Du, C., Fang, M., Li, Y., Li, L., and Wang, X. (2000) Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 102, 33-42.
237. Yang, X., Fraser, M., Moll, U.M., Basak, A., and Tsang, B.K. (2006) Akt-mediated cisplatin resistance in ovarian cancer: modulation of p53 action on caspase-dependent mitochondrial death pathway. Cancer Res. 66, 3126-3136.
238. Sansal, I. and Sellers, W.S. (2004) The biology and clinical relevance of the PTEN tumor suppressor pathway, J. Clin. Oncol. 22, 2954-2963. (Pubitemid 41079915)
239. Yang, H., Kong, W., He, L., Zhao, J.J., O'Donnell, J.D., Wang, J., Wenham, R.M., Coppola, D., Kruk, P.A., Nicosia, S.V., and Cheng, J.Q. (2008) MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. Cancer Res. 68, 425-433. (Pubitemid 351380068)
240. Yin, G., Chen, R., Alvero, A.B., Fu, H.H., Holmberg, J., Glackin, C., Rutherford, T., and Mor, G. (2010) TWISTing stemness, inflammation and proliferation of epithelial ovarian cancer cells through MIR199A2/214. Oncogene 29, 3545-3553.
241. Thigpen, J.T., Aghajanian, C.A., Alberts, D.S., Campos, S.M., Gordon, A.N., Markman, M., McMeekin, D.S., Monk, B.J., and Rose, P.G. (2005) Role of pegylated liposomal doxorubicin in ovarian cancer. Gynecol. Oncol. 96, 10-18. (Pubitemid 39612410)
242. Clarke-Pearson, D.L. (2009) Clinical practice-screening for ovarian cancer. N. Engl. J. Med. 361 (2), 170-177.
243. Bavoux, C., Leopoldino, A.M., Bergoglio, V., O-Wang, J., Ogi, T., Bieth, A., Judde, J.G., Pena, S.D., Poupon, M.F., Helleday, T., Tagawa, M., Machado, C., Hoffmann, J.S., and Cazaux, C. (2005) Up-regulation of the error-prone DNA polymerase {kappa} promotes pleiotropic genetic alterations and tumorigenesis. Cancer Res. 65, 325-330. (Pubitemid 40070825)
244. Miura, M., Miura, Y., Padilla-Nash, H.M., Molinolo, A.A., Fu, B., Patel, V., Seo, B.M., Sonoyama, W., Zheng, J.J., Baker, C.C., Chen, W., Ried, T., and Shi, S. (2006) Accumulated chromosomal instability in murine bone marrow mesenchymal stem cells leads to malignant transformation. Stem Cells 24, 1095-1103.
245. Nguyen, H.G. and Ravid, K. (2006) Tetraploidy/aneuploidy and stem cells in cancer promotion: the role of chromosome passenger proteins. J. Cell Physiol. 208, 12-22. (Pubitemid 43848985)
246. Weaver, B.A. and Cleveland, D.W. (2007) Aneuploidy: instigator and inhibitor of tumorigenesis. Cancer Res. 67, 10103-10105. (Pubitemid 350070779)
247. Williams, B.R., Prabhu, V.R., Hunter, K.E., Glazier, C.M., Whittaker, C.A., Housman, D.E., and Amon, A. (2008) Aneuploidy affects proliferation and spontaneous immortalization in mammalian cells. Science 322, 703-709.
248. Johnatty, S.E., Beesley, J., Paul, J., Fereday, S., Spurdle, A.B., Webb, P.M., Byth, K., Marsh, S., McLeod, H.; AOCS Study Group, Harnett, P.R., Brown, R., DeFazio, A., and Chenevix-Trench, G. (2008) ABCB1 (MDR 1) polymorphisms and progression-free survival among women with ovarian cancer following paclitaxel/carboplatin chemotherapy. Clin. Cancer Res. 14, 5594-5601.
249. Zheng, L.S., Wang, F., Li, Y.H., Zhang, X., Chen, L.M., Liang, Y.J., Dai, C.L., Yan, Y.Y., Tao, L.Y., Mi, Y.J., Yang, A.K., To, K.K., and Fu, L.W. (2009) Vandetanib (Zactima, ZD6474) antagonizes ABCC1- and ABCG2-mediated multidrug resistance by inhibition of their transport function. PLoS One 4(4), e5172.
250. Ma, L., Lai, D., Liu, T., Cheng, W., and Guo, L. (2010) Cancer stem-like cells can be isolated with drug selection in human ovarian cancer cell line SKOV3. Acta Biochim. Biophys. Sin. (Shanghai) 42, 593-602.
251. Borst, P. and Elferink, R.O. (2002) Mammalian ABC transporters in health and disease. Annu. Rev. Biochem. 71, 537-592. (Pubitemid 34800230)
252. Litman, T., Druley, T.E., Stein, W.D., and Bates, S.E. (2001) From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significance. Cell Mol. Life Sci. 58, 931-959. (Pubitemid 32652819)
253. Tang, L., Bergevoet, S.M., Gilissen, C., de Witte, T., Jansen, J.H., van der Reijden, B.A., and Raymakers, R.A. (2010) Hematopoietic stem cells exhibit a specific ABC transporter gene expression profile clearly distinct from other stem cells. BMC Pharmacol. 10, 12.
254. Dean, M., Rzhetsky, A., and Allikmets, R. (2001) The human ATP-binding cassette (ABC) transporter superfamily. Genome Res. 11, 1156-1166. (Pubitemid 32677289)
255. Piehler, A.P., Hellum, M., Wenzel, J.J., Kaminski, E., Haug, K.B., Kierulf, P., and Kaminski, W.E. (2008) The human ABC transporter pseudogene family: evidence for transcription and gene-pseudogene interference. BMC Genomics 9, 165.
256. Kelly, L., Fukushima, H., Karchin, R., Gow, J.M., Chinn, L.W, Pieper, U., Segal, M.R., Kroetz, D.L., and Sali, A. (2010) Functional hot spots in human ATP-binding cassette transporter nucleotide binding domains. Protein Sci. 19, 2110-2121.
257. Calcagno, A.M., Fostel, J.M., To, K.K., Salcido, C.D., Martin, S.E., Chewning, K.J., Wu, C.P., Varticovski, L., Bates, S.E., Caplen, N.J., and Ambudkar, S.V. (2008) Single-step doxorubicin-selected cancer cells overexpress the ABCG2 drug transporter through epigenetic changes. Br. J. Cancer 98, 1515-1524 (Pubitemid 351652329)